Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alan Dunton joins EpiCept as non-executive chair

This article was originally published in Scrip

Executive Summary

EpiCept Corporation, focused on the development and commercialisation of treatments for cancer and pain, has appointed Dr Alan Dunton to its board of directors as non-executive chair. Dr Dunton replaces Bob Savage, who will remain on the board as a director. Dr Dunton is the founder of Danerius, a consulting company that advises pharma and biotech companies on issues related to drug development. He is also a director at Targacept, Palatin Technologies and Oragenics. He previously served as president and CEO of Panacos Pharmaceuticals.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts